The aim of the current study was to characterize and compare the effects of specific SphK1-activating agents on the intracellular localization of SphK1 and S1P3 in ER-positive MCF-7 breast cancer cells and MCF-7-derived, BCSC-enriched mammospheres. This evidence concerns the gene SPHK1 and breast cancer.